Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first1,981 to 2,000 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| PMP22 peripheral myelin protein 22 | 5376 HGNC:9118 | 1 | 69 | 0 | 0 | 1,361 | 3,310 |
| LTBR lymphotoxin beta receptor | 4055 HGNC:6718 | 1 | 104 | 1 | 0 | 2,138 | 3,299 |
| ME2 malic enzyme 2 | 4200 HGNC:6984 | 1 | 26 | 0 | 0 | 1,820 | 3,297 |
| XPA XPA, DNA damage recognition and repair factor | 7507 HGNC:12814 | 1 | 49 | 0 | 0 | 1,816 | 3,297 |
| ALPL alkaline phosphatase, biomineralization associated | 249 HGNC:438 | 1 | 177 | 0 | 0 | 1,408 | 3,295 |
| KRT90P keratin 90, pseudogene | 85340 HGNC:30195 | 0 | 0 | 0 | 0 | 1,373 | 3,295 |
| TREM1 triggering receptor expressed on myeloid cells 1 | 54210 HGNC:17760 | 1 | 201 | 1 | 3 | 1,803 | 3,294 |
| NDRG1 N-myc downstream regulated 1 | 10397 HGNC:7679 | 1 | 52 | 0 | 0 | 1,937 | 3,293 |
| HTRA1 HtrA serine peptidase 1 | 5654 HGNC:9476 | 1 | 86 | 0 | 0 | 1,906 | 3,290 |
| PLA2G2A phospholipase A2 group IIA | 5320 HGNC:9031 | 1 | 104 | 2 | 5 | 1,438 | 3,288 |
| SOD3 superoxide dismutase 3 | 6649 HGNC:11181 | 1 | 45 | 0 | 0 | 1,947 | 3,288 |
| DSG1 desmoglein 1 | 1828 HGNC:3048 | 1 | 35 | 0 | 0 | 1,141 | 3,287 |
| CDC6 cell division cycle 6 | 990 HGNC:1744 | 1 | 61 | 0 | 0 | 1,788 | 3,285 |
| MIR133B microRNA 133b | 442890 HGNC:31759 | 0 | 0 | 0 | 0 | 1,034 | 3,285 |
| PBX1 PBX homeobox 1 | 5087 HGNC:8632 | 1 | 29 | 0 | 0 | 1,891 | 3,285 |
| FOXG1 forkhead box G1 | 2290 HGNC:3811 | 1 | 37 | 0 | 0 | 2,369 | 3,284 |
| APOA4 apolipoprotein A4 | 337 HGNC:602 | 1 | 37 | 0 | 0 | 1,802 | 3,283 |
| FPR2 formyl peptide receptor 2 | 2358 HGNC:3827 | 1 | 91 | 0 | 0 | 1,697 | 3,281 |
| ITPR1 inositol 1,4,5-trisphosphate receptor type 1 | 3708 HGNC:6180 | 1 | 19 | 0 | 0 | 2,123 | 3,280 |
| ADCYAP1 adenylate cyclase activating polypeptide 1 | 116 HGNC:241 | 1 | 59 | 0 | 0 | 1,702 | 3,279 |
Code
curl "https://conductscience.org/api/genes/v1?page=100"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=100
{
"data": {
"total": 193990,
"results": [
{
"id": "5376",
"title": "PMP22: peripheral myelin protein 22",
"summary": "NCBI Gene 5376. 1 protein, 69 patents, 0 drugs, 0 trials, 1,361 NIH grants and 3,310 papers.",
"record": "/library/genes/5376",
"gene_id": 5376,
"symbol": "PMP22",
"name": "peripheral myelin protein 22",
"hgnc_id": "HGNC:9118",
"counts": {
"proteins": 1,
"patents": 69,
"drugs": 0,
"trials": 0,
"grants": 1361,
"papers": 3310
}
},
{
"id": "4055",
"title": "LTBR: lymphotoxin beta receptor",
"summary": "NCBI Gene 4055. 1 protein, 104 patents, 1 drug, 0 trials, 2,138 NIH grants and 3,299 papers.",
"record": "/library/genes/4055",
"gene_id": 4055,
"symbol": "LTBR",
"name": "lymphotoxin beta receptor",
"hgnc_id": "HGNC:6718",
"counts": {
"proteins": 1,
"patents": 104,
"drugs": 1,
"trials": 0,
"grants": 2138,
"papers": 3299
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=101",
"request_id": "bMdmYXi10plVv1DG"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant